TMO Oct 2019 290.000 put

OPR - OPR Delayed Price. Currency in USD
7.00
-4.70 (-40.17%)
As of 3:58PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close11.70
Open6.15
Bid7.20
Ask7.80
Strike290.00
Expire Date2019-10-18
Day's Range5.70 - 7.25
Contract RangeN/A
Volume19
Open Interest548
  • Is Thermo Fisher Scientific (TMO) Outperforming Other Medical Stocks This Year?
    Zacks

    Is Thermo Fisher Scientific (TMO) Outperforming Other Medical Stocks This Year?

    Is (TMO) Outperforming Other Medical Stocks This Year?

  • Thermo Fisher Gets a Boost from Buyouts and Global Expansion
    Zacks

    Thermo Fisher Gets a Boost from Buyouts and Global Expansion

    Thermo Fisher (TMO) registers a solid international performance with strong growth in Europe and Asia-Pacific including China.

  • The Zacks Analyst Blog Highlights: Microsoft, Royal Dutch, IBM, Thermo Fisher and American Tower
    Zacks

    The Zacks Analyst Blog Highlights: Microsoft, Royal Dutch, IBM, Thermo Fisher and American Tower

    The Zacks Analyst Blog Highlights: Microsoft, Royal Dutch, IBM, Thermo Fisher and American Tower

  • Top Stock Reports for Microsoft, Royal Dutch Shell & IBM
    Zacks

    Top Stock Reports for Microsoft, Royal Dutch Shell & IBM

    Top Stock Reports for Microsoft, Royal Dutch Shell & IBM

  • Should You Worry About Thermo Fisher Scientific Inc.'s (NYSE:TMO) CEO Salary Level?
    Simply Wall St.

    Should You Worry About Thermo Fisher Scientific Inc.'s (NYSE:TMO) CEO Salary Level?

    Marc Casper has been the CEO of Thermo Fisher Scientific Inc. (NYSE:TMO) since 2009. First, this article will compare...

  • Thomson Reuters StreetEvents

    Edited Transcript of TMO earnings conference call or presentation 24-Jul-19 12:30pm GMT

    Q2 2019 Thermo Fisher Scientific Inc Earnings Call

  • Thermo Fisher Closes API Site Buyout, Fortifies Pharma Unit
    Zacks

    Thermo Fisher Closes API Site Buyout, Fortifies Pharma Unit

    Following the acquisition closure of GlaxoSmithKline's plant, Thermo Fisher (TMO) will continue to manufacture APIs for the same under a multi-year supply agreement.

  • Dow Jumps 300 Points Friday
    GuruFocus.com

    Dow Jumps 300 Points Friday

    Smart Global Holdings jumps on 4th-quarter results Continue reading...

  • Here is Hedge Funds’ 28th Highest Ranked Stock Pick
    Insider Monkey

    Here is Hedge Funds’ 28th Highest Ranked Stock Pick

    With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second quarter. One of these stocks was Thermo Fisher Scientific Inc. (NYSE:TMO). Is Thermo Fisher Scientific Inc. […]

  • Here's Why You Should Add Thermo Fisher to Your Portfolio
    Zacks

    Here's Why You Should Add Thermo Fisher to Your Portfolio

    Investors continue to be optimistic about Thermo Fisher's (TMO) performance.

  • Zacks.com featured highlights include: Booz Allen Hamilton, Thermo Fisher Scientific, Target, Microsoft and Barrel Old Country Store
    Zacks

    Zacks.com featured highlights include: Booz Allen Hamilton, Thermo Fisher Scientific, Target, Microsoft and Barrel Old Country Store

    Zacks.com featured highlights include: Booz Allen Hamilton, Thermo Fisher Scientific, Target, Microsoft and Barrel Old Country Store

  • Investors Binge on Record $308 Billion of Company Bond Sales
    Bloomberg

    Investors Binge on Record $308 Billion of Company Bond Sales

    (Bloomberg) -- Companies globally sold a record amount of bonds in September as investors hungry for yield poured into debt, betting that major central banks can keep the global economy out of a recession and the worst can be avoided in the U.S.-China trade war.Firms from Apple Inc. to France’s Orange and Japan’s SoftBank Group Corp. sold more than $308 billion of notes, the first time ever that corporate issuance has topped the $300 billion mark in a month, according to data compiled by Bloomberg. Sales globally this year are on track to exceed the equivalent of $2 trillion at the fastest pace ever.The onslaught of investment-grade deals in the U.S. may ease to about $200 billion in the last quarter as tight spreads potentially make investors more cautious and they position for 2020, JPMorgan Chase & Co. said. Pacific Investment Management Co. said last month that it is “cautious” on corporate credit, and favors short-dated names and those that are less likely to default.“To the extent that new issuance is credit enhancing -- refinancing and or extending the maturities of its debt -- then the issuance is good for the companies as well the current bondholders,” said Todd Schubert, head of fixed-income research at Bank of Singapore Ltd. “Many of the issues that I have seen fall under this category.”‘Massive Snowball’ Effect to Spur China Bond Defaults AbroadEuropean surgeIn Europe, corporate bond sales have already set a full-year record with three months still left to go. Year-to-date investment-grade euro corporate bond issuance reached 582 billion euros ($636 billion) Tuesday, beating full-year totals dating back to at least 2014, Bloomberg data show. The tally includes 94.5 billion euros of September deals, well above a previous 90.3 billion euros record set in January.U.S. borrowers such as Medtronic Plc and Thermo Fisher Scientific Inc. have sold a market-leading 68 billion euros of bonds this year, partly to refinance costlier dollar debt. That tally is set to go even higher, with computer maker Dell Technologies Inc meeting investors from today for a planned debut sale of euro bonds, according to a person with knowledge of the matter, who declined to be identified citing company policy.“Fifty billion euros-plus is easily achievable in the final quarter, even if the markets generally start to wobble in the face of macro and/or geopolitical event risk,“ said Suki Mann, founder of Creditmarketdaily.com, in a note to clients. He believes treasury desks are likely to “opportunistically pre-fund obligations which might not be maturing for another twelve months.”U.S. RecordsSeptember’s new U.S. investment-grade debt supply reached $158 billion, making it the third-largest month ever for issuance. It was a month for the record books: an unprecedented 130 issuers tapped debt capital markets after a frenzied start that made the first week the busiest market participants had seen in their careers.The market’s ability to digest the supply boom was just as notable as the sheer volume of borrowers that came to market. Global demand for higher-yielding U.S. corporate debt underpinned sales, and investment-grade spreads closed about 5 basis points tighter over the course of September, finishing at 115 basis points over Treasuries Monday.Risks have caught up with more borrowers recently, though. Corporate defaults in 2019 worldwide already match those in 2018, with 82 globally this year, S&P Global Ratings said on Sept. 26.Still, with the global economy seen growing at or just below 3%, a lack of clear direction in U.S. interest rates, and a possible pause in U.S.-China trade tensions, Goldman Sachs Group Inc. expects the search for yield among investors to continue. Those factors are supportive of the bank’s preference for high-yield bonds over investment grade in Asia, it said in a report Friday.(Updates with U.S. September supply details from eighth paragraph)\--With assistance from Brian Smith, Claire Boston and Michael Gambale.To contact the reporters on this story: Finbarr Flynn in Tokyo at fflynn3@bloomberg.net;Hannah Benjamin in London at hbenjamin1@bloomberg.netTo contact the editors responsible for this story: Andrew Monahan at amonahan@bloomberg.net, ;Vivianne Rodrigues at vrodrigues3@bloomberg.net, Beth ThomasFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

  • Behind the scenes at Thermo Fisher, where high-powered microscopes come to life (Photos)
    American City Business Journals

    Behind the scenes at Thermo Fisher, where high-powered microscopes come to life (Photos)

    The company, which has a large outpost in Hillsboro, makes the microscopes that are advancing structural biology.

  • 7 Dividend Growth Stocks to Buy for October
    Zacks

    7 Dividend Growth Stocks to Buy for October

    Dividend-paying securities are a major source of consistent income for investors when returns from the equity market are at risk.

  • Thermo Fisher Scientific Completes Acquisition of GSK Manufacturing Site in Cork, Ireland
    PR Newswire

    Thermo Fisher Scientific Completes Acquisition of GSK Manufacturing Site in Cork, Ireland

    WALTHAM, Mass. , Oct. 1, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has completed its previously announced acquisition of an active pharmaceutical ...

  • Roper (ROP) Agrees to Sell Gatan to AMETEK for $925M in Cash
    Zacks

    Roper (ROP) Agrees to Sell Gatan to AMETEK for $925M in Cash

    Roper's (ROP) Gatan divestment, to be completed in the fourth quarter of 2019, will help it concentrate on its core and profitable businesses.

  • Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 23, 2019
    PR Newswire

    Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 23, 2019

    WALTHAM, Mass. , Sept. 30, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter ...

  • Reuters

    UPDATE 1-Ametek to buy Roper Tech's unit for $925 mln

    Electronic instruments maker Ametek Inc said on Friday it would buy a unit of Roper Technologies Inc, Gatan Inc, for $925 million in cash, a few months after Thermo Fisher Scientific Inc scrapped its plan to buy the business. Gatan makes specialized "peripherals" such as filters and cameras used in electron microscopes, while Ametek manufactures instruments used in various industries ranging from aerospace and defense to oil and gas. Thermo Fisher's $925 million deal to buy Gatan collapsed after Britain's Competition and Markets Authority launched an in-depth inquiry into the deal..

  • Is Thermo Fisher Scientific (TMO) Stock Outpacing Its Medical Peers This Year?
    Zacks

    Is Thermo Fisher Scientific (TMO) Stock Outpacing Its Medical Peers This Year?

    Is (TMO) Outperforming Other Medical Stocks This Year?

  • PR Newswire

    Thermo Fisher Scientific Prices Offering of Senior Notes

    WALTHAM, Mass. , Sept. 25, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) (" Thermo Fisher ") announced today that it has priced an offering of €4.4 billion aggregate principal ...

  • Moody's

    Thermo Fisher Scientific Inc. -- Moody's rates Thermo Fisher's new senior unsecured notes Baa1

    Moody's Investors Service (Moody's) assigned a Baa1 rating to Thermo Fisher Scientific Inc.'s ("Thermo Fisher") new senior unsecured notes. Proceeds from the approximately €4.4 billion of new European notes and $900 million of new U.S. notes will be used for refinancing purposes with the intent of extending the company's maturity profile and reducing interest expense. Thermo Fisher's adjusted debt to EBITDA was 3.2 times as of June 30, 2019.

  • 4 Stocks to Focus on Global Biotechnology Reagents Market
    Zacks

    4 Stocks to Focus on Global Biotechnology Reagents Market

    Increased use of reagents in the field of research, bioscience and genetics is pushing the biotechnology reagents market higher.

  • Did You Miss Thermo Fisher Scientific's (NYSE:TMO) Impressive 142% Share Price Gain?
    Simply Wall St.

    Did You Miss Thermo Fisher Scientific's (NYSE:TMO) Impressive 142% Share Price Gain?

    When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...